Research on genomic test utilizing next generation sequencer for solid tumors and development of the genome database
Not Applicable
- Registration Number
- JPRN-UMIN000028388
- Lead Sponsor
- iigata University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 995
Inclusion Criteria
Not provided
Exclusion Criteria
None
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Development of genome database
- Secondary Outcome Measures
Name Time Method Development of genome analytic technologies Association between genomic alterations and the sensitivity of anti-cancer drugs Development of artificial intelligence to predict genomic aberrations and the response of anti-cancer drugs in patients with solid tumors